Literature DB >> 1326626

Concentration- and time-dependence of phosphoinositide hydrolysis induced by endothelin-1 in relation to the positive inotropic effect in the rabbit ventricular myocardium.

M Takanashi1, M Endoh.   

Abstract

The effects of endothelin-1 on phosphoinositide hydrolysis in relation to the positive inotropic effect of the compound were studied in the rabbit ventricular myocardium. Endothelin-1 elicited a concentration- and time-dependent accumulation of [3H]inositol monophosphate (IP1) in ventricular muscle slices prelabeled with myo-[3H]inositol in concentrations similar to those that caused a positive inotropic effect. The EC50 value of endothelin-1, both for the induction of [3H]IP1 accumulation and for the positive inotropic effect was 6 x 10(-9) M. The endothelin-induced positive inotropic effect was linearly related to [3H]IP1 accumulation. Endothelin-1 induced a small transient negative inotropic effect before the onset of a gradually developing and sustained positive inotropic effect which reached a steady level at 30 min. After administration of endothelin-1, [3H]IP3 accumulated rapidly and transiently before the development of the positive inotropic effect. [3H]IP2 accumulated slowly and peaked at 20 min. [3H]IP1 accumulation occurred more slowly and of the inositol phosphates its time course coincided best with that of the positive inotropic effect. Phorbol 12,13-dibutyrate inhibited both the [3H] IP1 accumulation and positive inotropic effect induced by endothelin-1. The present results indicate that an acceleration of phosphoinositide hydrolysis induced by activation of endothelin-1 receptors may be responsible for induction of the positive inotropic effect of endothelin-1 on rabbit ventricular myocardium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326626

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Modeling hypertrophic IP3 transients in the cardiac myocyte.

Authors:  Michael Cooling; Peter Hunter; Edmund J Crampin
Journal:  Biophys J       Date:  2007-08-10       Impact factor: 4.033

2.  Pharmacological characteristics of endothelin receptors in the rabbit ventricular myocardium: the nonselective endothelin receptor antagonist PD 145065 antagonizes the positive inotropic effect of endothelin-3 but not of endothelin-1.

Authors:  I Norota; M Endoh
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 3.  Cardiac alpha(1)-adrenoceptors that regulate contractile function: subtypes and subcellular signal transduction mechanisms.

Authors:  M Endoh
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

4.  Role of Na+/Ca2+ exchange in endothelin-1-induced increases in Ca2+ transient and contractility in rabbit ventricular myocytes: pharmacological analysis with KB-R7943.

Authors:  H T Yang; K Sakurai; H Sugawara; T Watanabe; I Norota; M Endoh
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

5.  Pharmacological analysis by HOE642 and KB-R9032 of the role of Na(+)/H(+) exchange in the endothelin-1-induced Ca(2+) signalling in rabbit ventricular myocytes.

Authors:  H Wang; K Sakurai; M Endoh
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Mechanisms of endothelin-1-induced decrease in contractility in adult mouse ventricular myocytes.

Authors:  K Nishimaru; Y Miura; M Endoh
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

7.  Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis.

Authors:  A Ishihata; M Endoh
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Mechanical effects of ET-1 in cardiomyocytes isolated from normal and heart-failed rabbits.

Authors:  E J Kelso; R F Geraghty; B J McDermott; E R Trimble; D P Nicholls; B Silke
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.